
Opinion|Videos|June 10, 2024
Efficacy and Safety Data from SunRISe-1
The panel reviews data from the SunRISe-1 trial investigating TAR-200 and offers its impressions on the efficacy and safety findings.
Advertisement
Episodes in this series

Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: Diet and Prostate Cancer, with Stephen J. Freedland, MD
2
67Cu-SAR-bisPSMA continues to show promise in mCRPC
3
How menstrual cycles influence bladder and pelvic floor symptoms
4
RCMIGI trial supports feasibility of reduced margins in image-guided prostate radiotherapy
5




















